Partner Gardner Davis discussed Procter & Gamble’s unusual move in declaring victory in its proxy battle with activist investor Nelson Peltz and his Trian Fund Management in a Fortune article, “P&G Did Something Odd in Declaring Victory Against Nelson Peltz.”
P&G submitted an 8K regulatory filing announced the preliminary outcome of the vote and relied on estimates. The filing included a footnote which offered at least areas in which it has deployed estimates of the tally.
“I don’t ever recall seeing a footnote like the one in P&G’s 8K,” Davis said. “This is so much of a high-stakes battle. I think they were under tremendous pressure to declare victory.”
P&G submitted an 8K regulatory filing announced the preliminary outcome of the vote and relied on estimates. The filing included a footnote which offered at least areas in which it has deployed estimates of the tally.
“I don’t ever recall seeing a footnote like the one in P&G’s 8K,” Davis said. “This is so much of a high-stakes battle. I think they were under tremendous pressure to declare victory.”
People
Related News
April 3, 2026
In the News
David Rosen Weighs in on FDA's Pharma PR Crackdown – 'Stick to the Data'
Foley & Lardner LLP partner David Rosen shared insights on the regulatory challenges pharmaceutical companies face when publicly communicating around new cancer therapies in the MM+M article, “When a podcast becomes promotion: Inside the FDA’s warning shot at ImmunityBio.”
April 2, 2026
In the News
Susan Poll Klaessy and Adrienne Walker Named Chair and Vice Chair of Foley’s Bankruptcy & Business Reorganizations Practice
Foley & Lardner LLP partner Susan Poll Klaessy was appointed chair of the firm’s global Bankruptcy & Business Reorganizations Practice Group. Partner Adrienne Walker will serve as vice chair, supporting the continued growth and strategic direction of the practice.
April 1, 2026
In the News
Foley Featured on Top 10 Sales of 2025 List by Golf Inc.
Foley & Lardner LLP advised on two transactions named among Golf Inc.’s Top 10 Sales of 2025.